Patent details

Basic Information

Publication number:

EP2308975

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP100107952

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Antibody molecules having specificity for human tumor necrosis factor alpha, and use thereof

French Title of Invention:

Molécules d'anticorps dotées d'une spécificité pour le facteur alpha humain de nécrose de tumeur et leurs utilisations

German Title of Invention:

Antikörpermoleküle mit Spezifizität für menschlichen Tumornekrosefaktor-alpha, und deren Verwendung

SPC Number:

Dates

Filing date:

05/06/2001

Grant date:

10/08/2016

EP Publication Date:

10/08/2016

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

13/04/2011

EP B1 Publication Date:

10/08/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

05/06/2021

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

05/06/2001

 

 

Name:

UCB PHARMA, S.A.

Address:

ALLÉE DE LA RECHERCHE 60, 1070 BRUSSELS, Belgium (BE)

Inventor

1

Name:

King David John

Address:

United Kingdom (GB)

2

Name:

Chapman Andrew Paul

Address:

United Kingdom (GB)

3

Name:

Weir Andrew Neil Charles

Address:

United Kingdom (GB)

4

Name:

Brown Derek Thomas

Address:

United Kingdom (GB)

5

Name:

Athwal Diljeet Singh

Address:

United Kingdom (GB)

6

Name:

Popplewell Andrew George

Address:

United Kingdom (GB)

Priority

Priority Number:

0013810

Priority Date:

06/06/2000

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C12N 15/13;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

26/05/2020

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages